Biotech firm pulls pioneering gene therapy due to no demand – Business Insider
Business Insider |
Biotech firm pulls pioneering gene therapy due to no demand
Business Insider LONDON, April 20 (Reuters) – The biotech company behind the Western world's first gene therapy and the most expensive prescription medicine in history is giving up on the product because of lack of demand. Only one patient has been treated commercially … First Gene Therapy Ever Approved Calling it Quits UniQure to Yank Pioneering Gene Therapy From Market in Europe Hard-fought approval to commercial flop: Uniqure pulls plug on gene therapy |
